Apolipoprotein E type 4 allele and Alzheimer's disease: Effect on age at onset and relative risk in different age groups

Journal of Neurology

Volumn 243, Issue 6, 1996, Pages 452-456

  Kurz, Alexander ^a   Altland, Klaus ^b   Lautenschlager, Nicola ^a   Zimmer, Reinhilde ^a   Busch, Raymonde ^a   Gerundt, Ina ^b   Lauter, Hans ^a   Müller, Ulrich ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Age at onset; Alzheimer's disease; Apolipoprotein E; Relative risk

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; GENOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; ONSET AGE; PREDICTION; PRIORITY JOURNAL; RISK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK;

EID: 0029893288     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00900498     Document Type: Article

References (36)

1. American College of Medical Genetics (1995) Consensus statement: statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 274: 1627-1629
2. Benjamin R, Leake A, Edwardson JA, McKeith JG, Ince PG, Perry RH, Morris CM (1994) Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 343: 1565
3. Bird TD (1995) Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 38: 2-4
4. Chartier-Harlin MC, Parfitt M, Legrain S, Pérez-Tur J, Bousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V, et al (1994) Apolipoprotein E, ε4-allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3: 564-574
5. Corder B, Saunders AM, Strittmatter WJ, Haines J, Pericak-Vance MA, Roses AD (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
6. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Coneally PM, Schmader KE, et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7: 180-184
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Coneally PM, Schmader KE, Tanzi RE, et al (1995) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45: 1323-1328
8. Dai XY, Nanko S, Hattori M, Fukuda R, Nagata K, Isse K, Ueki A, Kazamatsuri H (1994) Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett 175: 74-76
9. Dixon WJ, Brown MB, Engelman L, Jendrich RJ (1990) BMDP Statistical Software. University of California Press, Berkeley
10. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschnini G, Trabucchi M (1995) Gene dose of the e4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 37: 596-604
11. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L (1994) The apolipoprotein E allele e4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 44: 1950-1951
12. Hardy J, Houlden H, Collinge J, Kennedy A, Newman S, Rossor M, Lannfelt L, Lilius L, Winblad B, Crook R, et al (1993) Apolipoprotein E genotype and Alzheimer's disease (letter). Lancet 342: 737-738
13. Kessler J, Markowitsch HJ, Denzler PE (1990) Mini-Mental-Status-Test. Deutsche Fassung. Beltz, Weinheim
14. Kurz A, Haupt M, Müllers-Stein M, Zimmer R, Lauter H (1991) Alzheimer-Sprechstunde: Erfahrungen in der Diagnostik und Therapie von organisch bedingten psychischen Störungen. Psychiatr Prax 18: 109-114
15. Kurz A, Lautenschlager N, Haupt M, Zimmer R, von Thülen B, Altlandt K, Lauter H, Müller U (1994) Das Apolipoprotein-E-e4-Allel ist ein Risiko-faktor für die Alzheimer-Krankheit mit frühem und spätem Beginn. Nervenarzt 65: 774-779
16. Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB, Müller U (1996) Apolipoprotein E allele ε4, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology (in press)
17. Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala EL, Vanhanen M, Hänninen T, Pyörälä K, Kesäniemi YA, Riekkinen P, et al (1994) Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 309: 636-638
18. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tyeko B, Ginsberg H (1993) The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 34: 752-754
19. Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirier J (1994) Predictive value of apolipoprotein e genotyping in Alzheimer's disease: results of an autopsy series and analysis of several combined studes. Ann Neurol 36: 889-895
20. Norusis MJ (1990) SPSS for the Macintosh: operations guide. SPSS, Chicago
21. Rebeck GW, Hyman BT (1995) Apolipoprotein E - correction. Neurology 45: 598
22. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-580
23. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT (1994) Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 44: 1513-1516
24. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on apoE genotype and duration of disease. J Neuropathol Exp Neurol 53: 429-437
25. Roses AD (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 38: 6-14
26. Saunders AM, Schmader K, Breitner JCS, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McCown N, et al (1993) Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710-711
27. Saunders AM, Strittmatter WJ, Schmechel D, St.George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al (1993) Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
28. Schmechel DEA, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid b-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90: 9649-9653
29. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-1981
30. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer's disease. Proc Natl Acad Sci USA 91: 11183-11186
31. Tsai MS, Tangalos EG, Petersen RC, Smith GE, Schaid DJ, Kokmen E, Ivnik RJ, Thibodeau SN (1994) Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 54: 643-649
32. Van Duijn CM, Knijff P de, Cruts M, Wehnert A, Havekes LM, Hofman A, van Broeckhoven C (1994) Apolipoprotein e4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 7: 74-78
33. Van Duijn CM, Knijff P de, Wehnert A, Voecht J de, Bronzova JB, Havekes LM, Hofman A, Broeckhoven C van (1995) The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 37: 605-610
34. Wenham PR, Price WH, Blundell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158-1159
35. West HL, Rebeck GW, Growdon JH, Hyman BT (1995), Apolipoprotein E4 affects neuropathology but not clinical progression in Alzheimer's disease. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (eds) Research advances in Alzheimer's disease and related disorders. Wiley, Chichester, pp 363-370
36. WHO (1987) I.C.D. 10 - organic, including symptomatic, mental disorders. Diagnostic criteria for research. WHO document number 0645d. World Health Organization, Geneva